Investigational Stem cell treatment for congestive heart failure patients

Trial ID:
Thomas Heywood, M.D.
This study will compare an investigational stem cell procedure to a sham procedure. Patients will be required to have 2-3 days of screening, stay overnight in the hospital for the procedure, and attend follow-up visits at least every 6 months. Phone call contacts will be done each month.

Inclusion Criteria

  • Have an Ejection Fraction of 40% or less
  • Have had a hospitalization for heart failure within the last 9 months
  • Be on diuretics
  • Be on maximum tolerated heart failure medications
  • Be NYHA class 2-3
  • Meet all other eligibility criteria

Exclusion Criteria

  • Have severe COPD
  • Be unable to walk
  • Have an aortic valve prosthesis
  • Have been treated with any active stem cell product
  • Be in another clinical trial

Additional Info

  • The goal of this study is to evaluate the safety and effectiveness of the investigational stem cell product for restoring heart muscle function.

Contact Info:

  • Heather Catchpole
  • 858-824-4248